Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 24 | 2025 | 114 | 5.910 |
Why?
|
| Air Pollution | 18 | 2024 | 74 | 4.380 |
Why?
|
| Environmental Exposure | 22 | 2025 | 234 | 3.740 |
Why?
|
| Particulate Matter | 19 | 2025 | 79 | 3.710 |
Why?
|
| Maternal Exposure | 22 | 2025 | 156 | 3.690 |
Why?
|
| Occupational Exposure | 27 | 2022 | 131 | 3.370 |
Why?
|
| Environmental Monitoring | 25 | 2022 | 90 | 3.170 |
Why?
|
| Metals, Heavy | 3 | 2021 | 23 | 1.870 |
Why?
|
| Texas | 37 | 2025 | 3629 | 1.870 |
Why?
|
| Stillbirth | 3 | 2019 | 103 | 1.720 |
Why?
|
| Cyclonic Storms | 4 | 2021 | 79 | 1.630 |
Why?
|
| Industry | 10 | 2021 | 29 | 1.600 |
Why?
|
| Metals | 4 | 2023 | 66 | 1.600 |
Why?
|
| Arsenic | 4 | 2023 | 48 | 1.430 |
Why?
|
| Community-Based Participatory Research | 2 | 2023 | 60 | 1.430 |
Why?
|
| Residence Characteristics | 6 | 2020 | 286 | 1.410 |
Why?
|
| Disasters | 3 | 2021 | 106 | 1.370 |
Why?
|
| Mexican Americans | 6 | 2018 | 167 | 1.300 |
Why?
|
| Environmental Pollutants | 6 | 2018 | 78 | 1.260 |
Why?
|
| Premature Birth | 5 | 2018 | 419 | 1.250 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2024 | 242 | 1.250 |
Why?
|
| Ozone | 3 | 2019 | 19 | 1.180 |
Why?
|
| Stress, Psychological | 6 | 2021 | 574 | 1.120 |
Why?
|
| Oil and Gas Industry | 2 | 2018 | 5 | 1.110 |
Why?
|
| Pregnancy | 32 | 2025 | 7566 | 1.080 |
Why?
|
| Environmental Health | 3 | 2023 | 17 | 1.000 |
Why?
|
| Nitrogen Dioxide | 7 | 2025 | 18 | 0.880 |
Why?
|
| Recycling | 2 | 2020 | 5 | 0.830 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.730 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 7 | 2022 | 77 | 0.720 |
Why?
|
| Volatile Organic Compounds | 2 | 2020 | 13 | 0.720 |
Why?
|
| Deer | 1 | 2021 | 14 | 0.690 |
Why?
|
| Adult | 46 | 2025 | 31568 | 0.680 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 147 | 0.680 |
Why?
|
| Population Dynamics | 2 | 2019 | 33 | 0.680 |
Why?
|
| Disaster Planning | 1 | 2021 | 63 | 0.670 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 637 | 0.660 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 18 | 0.650 |
Why?
|
| Fires | 1 | 2020 | 12 | 0.640 |
Why?
|
| Benzene | 7 | 2020 | 24 | 0.630 |
Why?
|
| Humans | 98 | 2025 | 132062 | 0.620 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 16 | 0.620 |
Why?
|
| Temperature | 1 | 2019 | 303 | 0.580 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 114 | 0.580 |
Why?
|
| Natural Gas | 1 | 2018 | 5 | 0.570 |
Why?
|
| Female | 66 | 2025 | 70712 | 0.570 |
Why?
|
| Young Adult | 23 | 2023 | 9957 | 0.560 |
Why?
|
| Logistic Models | 14 | 2019 | 1838 | 0.540 |
Why?
|
| Trace Elements | 1 | 2017 | 24 | 0.520 |
Why?
|
| Urban Population | 6 | 2019 | 244 | 0.500 |
Why?
|
| Butadienes | 1 | 2016 | 22 | 0.500 |
Why?
|
| Hazardous Substances | 5 | 2015 | 18 | 0.500 |
Why?
|
| Models, Statistical | 7 | 2025 | 492 | 0.490 |
Why?
|
| Social Class | 2 | 2017 | 204 | 0.490 |
Why?
|
| Leukemia | 1 | 2019 | 370 | 0.480 |
Why?
|
| Community Participation | 1 | 2015 | 42 | 0.470 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 632 | 0.460 |
Why?
|
| Multilingualism | 1 | 2015 | 43 | 0.460 |
Why?
|
| Inhalation Exposure | 5 | 2020 | 35 | 0.460 |
Why?
|
| Surveys and Questionnaires | 9 | 2021 | 3990 | 0.450 |
Why?
|
| Air Pollutants, Occupational | 7 | 2006 | 17 | 0.440 |
Why?
|
| Hypertension | 3 | 2018 | 1396 | 0.430 |
Why?
|
| Birth Weight | 6 | 2025 | 350 | 0.430 |
Why?
|
| Occupational Diseases | 6 | 2016 | 74 | 0.420 |
Why?
|
| Models, Theoretical | 7 | 2015 | 392 | 0.420 |
Why?
|
| Case-Control Studies | 12 | 2019 | 3418 | 0.420 |
Why?
|
| Pilot Projects | 5 | 2020 | 1450 | 0.410 |
Why?
|
| Birth Certificates | 3 | 2019 | 13 | 0.380 |
Why?
|
| Risk Assessment | 7 | 2021 | 3736 | 0.380 |
Why?
|
| Infant, Newborn | 16 | 2025 | 8549 | 0.370 |
Why?
|
| Cohort Studies | 12 | 2022 | 5164 | 0.370 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 53 | 0.360 |
Why?
|
| Legionellosis | 1 | 2011 | 4 | 0.350 |
Why?
|
| Water Supply | 2 | 2004 | 26 | 0.350 |
Why?
|
| Linear Models | 7 | 2017 | 713 | 0.350 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 814 | 0.340 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 898 | 0.340 |
Why?
|
| Mercury | 2 | 2001 | 32 | 0.340 |
Why?
|
| Bayes Theorem | 7 | 2025 | 311 | 0.340 |
Why?
|
| Asthma | 7 | 2014 | 771 | 0.340 |
Why?
|
| Water Pollutants, Chemical | 2 | 2004 | 41 | 0.330 |
Why?
|
| Nickel | 2 | 2001 | 24 | 0.330 |
Why?
|
| Cities | 2 | 2020 | 49 | 0.320 |
Why?
|
| Polybrominated Biphenyls | 2 | 2007 | 6 | 0.310 |
Why?
|
| Particle Size | 4 | 2022 | 149 | 0.310 |
Why?
|
| Odds Ratio | 10 | 2016 | 1253 | 0.300 |
Why?
|
| Gestational Age | 5 | 2022 | 1224 | 0.300 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 329 | 0.300 |
Why?
|
| Respiratory Tract Diseases | 3 | 2020 | 80 | 0.300 |
Why?
|
| Agriculture | 2 | 2006 | 32 | 0.300 |
Why?
|
| Disinfection | 2 | 2011 | 29 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2013 | 568 | 0.290 |
Why?
|
| Pesticides | 3 | 2022 | 30 | 0.290 |
Why?
|
| Risk Factors | 17 | 2019 | 10941 | 0.290 |
Why?
|
| Male | 38 | 2023 | 64922 | 0.270 |
Why?
|
| Mining | 4 | 2010 | 7 | 0.270 |
Why?
|
| Metallurgy | 4 | 2000 | 6 | 0.260 |
Why?
|
| United States | 24 | 2019 | 11658 | 0.260 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 34 | 0.260 |
Why?
|
| Aerosols | 3 | 2022 | 64 | 0.250 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 13 | 0.250 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 60 | 0.240 |
Why?
|
| Prevalence | 11 | 2018 | 2658 | 0.240 |
Why?
|
| Biomarkers | 6 | 2017 | 3406 | 0.240 |
Why?
|
| Styrene | 4 | 2001 | 4 | 0.230 |
Why?
|
| Chemical Industry | 4 | 2001 | 7 | 0.220 |
Why?
|
| Cleft Lip | 2 | 2017 | 135 | 0.220 |
Why?
|
| Cleft Palate | 2 | 2017 | 154 | 0.220 |
Why?
|
| Risk | 3 | 2019 | 760 | 0.210 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 1824 | 0.210 |
Why?
|
| SEER Program | 3 | 2014 | 219 | 0.210 |
Why?
|
| Trihalomethanes | 1 | 2004 | 5 | 0.210 |
Why?
|
| United States Environmental Protection Agency | 3 | 2019 | 8 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2004 | 1227 | 0.200 |
Why?
|
| Data Collection | 4 | 2023 | 390 | 0.200 |
Why?
|
| Cobalt | 1 | 2022 | 18 | 0.190 |
Why?
|
| Tungsten | 1 | 2022 | 6 | 0.190 |
Why?
|
| Health Surveys | 3 | 2020 | 258 | 0.190 |
Why?
|
| Middle Aged | 20 | 2021 | 28964 | 0.180 |
Why?
|
| Glyoxylates | 1 | 2001 | 4 | 0.180 |
Why?
|
| Mandelic Acids | 1 | 2001 | 6 | 0.180 |
Why?
|
| Child | 10 | 2024 | 25789 | 0.180 |
Why?
|
| Toluene | 3 | 2010 | 11 | 0.180 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 144 | 0.180 |
Why?
|
| Xylenes | 3 | 2010 | 13 | 0.180 |
Why?
|
| Benzene Derivatives | 3 | 2010 | 18 | 0.180 |
Why?
|
| Soil | 1 | 2021 | 72 | 0.170 |
Why?
|
| China | 1 | 2021 | 290 | 0.170 |
Why?
|
| Floods | 1 | 2021 | 18 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 236 | 0.170 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 8 | 0.170 |
Why?
|
| Exercise | 2 | 2017 | 857 | 0.170 |
Why?
|
| Women, Working | 2 | 2017 | 9 | 0.170 |
Why?
|
| Spinal Dysraphism | 3 | 2015 | 274 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2007 | 3014 | 0.160 |
Why?
|
| Cadmium | 1 | 2020 | 31 | 0.160 |
Why?
|
| Food Contamination | 3 | 2007 | 27 | 0.160 |
Why?
|
| Soot | 1 | 2020 | 14 | 0.160 |
Why?
|
| Vehicle Emissions | 2 | 2022 | 21 | 0.160 |
Why?
|
| Feasibility Studies | 4 | 2017 | 828 | 0.160 |
Why?
|
| Styrenes | 3 | 1996 | 6 | 0.160 |
Why?
|
| Weather | 1 | 2019 | 14 | 0.160 |
Why?
|
| Aged | 14 | 2021 | 21406 | 0.160 |
Why?
|
| Regression Analysis | 5 | 2014 | 792 | 0.150 |
Why?
|
| Universities | 1 | 2020 | 129 | 0.150 |
Why?
|
| Urban Health | 1 | 2019 | 78 | 0.150 |
Why?
|
| RNA, Viral | 1 | 2021 | 562 | 0.150 |
Why?
|
| Oil and Gas Fields | 1 | 2019 | 9 | 0.150 |
Why?
|
| Child, Preschool | 8 | 2024 | 14751 | 0.150 |
Why?
|
| Sister Chromatid Exchange | 2 | 1996 | 15 | 0.150 |
Why?
|
| Adolescent | 13 | 2021 | 20562 | 0.150 |
Why?
|
| Registries | 3 | 2019 | 1572 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 196 | 0.140 |
Why?
|
| Analysis of Variance | 5 | 2001 | 1009 | 0.140 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 329 | 0.140 |
Why?
|
| Drinking Behavior | 1 | 1998 | 9 | 0.140 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 41 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2146 | 0.140 |
Why?
|
| Geography, Medical | 1 | 2017 | 18 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1539 | 0.130 |
Why?
|
| Occupations | 1 | 2017 | 19 | 0.130 |
Why?
|
| Fluorocarbons | 1 | 2017 | 59 | 0.130 |
Why?
|
| Workplace | 2 | 2015 | 82 | 0.130 |
Why?
|
| Retrospective Studies | 7 | 2025 | 17419 | 0.130 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 19 | 0.130 |
Why?
|
| Fetal Development | 3 | 2022 | 132 | 0.130 |
Why?
|
| Molecular Weight | 1 | 2017 | 309 | 0.130 |
Why?
|
| Neural Tube Defects | 2 | 2010 | 358 | 0.130 |
Why?
|
| DNA Adducts | 1 | 1996 | 72 | 0.130 |
Why?
|
| Serum Albumin | 1 | 1996 | 116 | 0.130 |
Why?
|
| Phthalic Acids | 1 | 2016 | 9 | 0.120 |
Why?
|
| Reproductive History | 1 | 1995 | 10 | 0.120 |
Why?
|
| Lead | 1 | 1995 | 24 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1203 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 30 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 74 | 0.110 |
Why?
|
| Publications | 1 | 2015 | 35 | 0.110 |
Why?
|
| Menopause | 1 | 1995 | 90 | 0.110 |
Why?
|
| Cause of Death | 2 | 2014 | 510 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2016 | 183 | 0.110 |
Why?
|
| Chlamydia trachomatis | 1 | 2014 | 27 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 985 | 0.110 |
Why?
|
| Focus Groups | 1 | 2015 | 224 | 0.110 |
Why?
|
| Cross-Sectional Studies | 7 | 2016 | 3761 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 7102 | 0.110 |
Why?
|
| Azithromycin | 1 | 2014 | 43 | 0.110 |
Why?
|
| Motor Activity | 2 | 2015 | 523 | 0.110 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 49 | 0.110 |
Why?
|
| Occupational Health | 3 | 2010 | 47 | 0.110 |
Why?
|
| Juvenile Delinquency | 1 | 2014 | 25 | 0.110 |
Why?
|
| Prisoners | 1 | 2014 | 38 | 0.110 |
Why?
|
| Environment Design | 1 | 2014 | 17 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 183 | 0.110 |
Why?
|
| Nutrition Surveys | 5 | 2016 | 314 | 0.110 |
Why?
|
| North America | 3 | 2000 | 264 | 0.110 |
Why?
|
| Smoking | 3 | 1996 | 938 | 0.110 |
Why?
|
| Iron | 1 | 2017 | 302 | 0.110 |
Why?
|
| Doxycycline | 1 | 2014 | 120 | 0.100 |
Why?
|
| Europe | 3 | 2000 | 372 | 0.100 |
Why?
|
| Uncertainty | 1 | 2014 | 101 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2016 | 202 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2015 | 130 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1381 | 0.100 |
Why?
|
| Population Surveillance | 3 | 2012 | 415 | 0.100 |
Why?
|
| Insurance Claim Reporting | 1 | 2012 | 7 | 0.100 |
Why?
|
| Poverty | 2 | 2015 | 446 | 0.100 |
Why?
|
| Infant | 7 | 2024 | 13064 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 358 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2012 | 43 | 0.090 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2003 | 12 | 0.090 |
Why?
|
| Iron, Dietary | 1 | 2012 | 15 | 0.090 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 2092 | 0.090 |
Why?
|
| Maintenance | 1 | 2011 | 1 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2002 | 41 | 0.090 |
Why?
|
| Gastroschisis | 1 | 2012 | 57 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 385 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 124 | 0.090 |
Why?
|
| Health Personnel | 2 | 2006 | 546 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 34882 | 0.090 |
Why?
|
| Equipment Contamination | 1 | 2011 | 41 | 0.090 |
Why?
|
| Demography | 3 | 2007 | 240 | 0.080 |
Why?
|
| Age Factors | 4 | 2015 | 2912 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 552 | 0.080 |
Why?
|
| Anencephaly | 1 | 2010 | 11 | 0.080 |
Why?
|
| Time Factors | 5 | 2001 | 6448 | 0.080 |
Why?
|
| Gasoline | 2 | 2022 | 4 | 0.080 |
Why?
|
| Parity | 2 | 2007 | 84 | 0.080 |
Why?
|
| Creatinine | 2 | 2001 | 412 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2014 | 843 | 0.070 |
Why?
|
| Research Design | 2 | 2007 | 741 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5409 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2022 | 6567 | 0.070 |
Why?
|
| Manufactured Materials | 2 | 1998 | 2 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2025 | 697 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2003 | 1491 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 364 | 0.070 |
Why?
|
| Dementia | 1 | 2013 | 459 | 0.070 |
Why?
|
| Incidence | 4 | 2023 | 3380 | 0.070 |
Why?
|
| Japan | 2 | 1998 | 157 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 444 | 0.070 |
Why?
|
| Cognition | 2 | 2024 | 810 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2955 | 0.070 |
Why?
|
| Michigan | 1 | 2007 | 50 | 0.070 |
Why?
|
| South Carolina | 1 | 2006 | 10 | 0.060 |
Why?
|
| Diet | 2 | 2011 | 1124 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 1009 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 435 | 0.050 |
Why?
|
| Chlorine | 1 | 2004 | 17 | 0.050 |
Why?
|
| Disinfectants | 1 | 2004 | 29 | 0.050 |
Why?
|
| Water Purification | 1 | 2004 | 19 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1517 | 0.050 |
Why?
|
| Fishes | 1 | 2003 | 35 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2011 | 1010 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2558 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2010 | 276 | 0.050 |
Why?
|
| Alloys | 1 | 2022 | 15 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1538 | 0.050 |
Why?
|
| Antimony | 1 | 2022 | 14 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2025 | 256 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2022 | 72 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 44 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 231 | 0.050 |
Why?
|
| Seasons | 1 | 2004 | 327 | 0.050 |
Why?
|
| Maximum Allowable Concentration | 1 | 2001 | 6 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2023 | 327 | 0.050 |
Why?
|
| Transients and Migrants | 1 | 2001 | 26 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2001 | 22 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2001 | 78 | 0.040 |
Why?
|
| Italy | 1 | 2001 | 131 | 0.040 |
Why?
|
| Sociological Factors | 1 | 2021 | 9 | 0.040 |
Why?
|
| Laboratories | 1 | 2022 | 89 | 0.040 |
Why?
|
| Medicaid | 2 | 2014 | 251 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1866 | 0.040 |
Why?
|
| Western Australia | 1 | 2000 | 5 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 34 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 491 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 430 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2010 | 1694 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1353 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 1998 | 20 | 0.040 |
Why?
|
| Baths | 1 | 1998 | 15 | 0.040 |
Why?
|
| Norway | 1 | 2017 | 27 | 0.030 |
Why?
|
| Menstruation | 1 | 2017 | 28 | 0.030 |
Why?
|
| Carcinogenicity Tests | 1 | 1996 | 20 | 0.030 |
Why?
|
| Biotransformation | 1 | 1996 | 56 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 657 | 0.030 |
Why?
|
| Employment | 1 | 2017 | 70 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 100 | 0.030 |
Why?
|
| Time | 1 | 1996 | 98 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 235 | 0.030 |
Why?
|
| Bias | 1 | 1996 | 143 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 64 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 189 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 65 | 0.030 |
Why?
|
| Workload | 1 | 2016 | 151 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 31 | 0.030 |
Why?
|
| Posture | 1 | 2015 | 144 | 0.030 |
Why?
|
| Income | 1 | 1995 | 138 | 0.030 |
Why?
|
| Postmenopause | 1 | 1995 | 153 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 42 | 0.030 |
Why?
|
| Food-Processing Industry | 1 | 1993 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 700 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 199 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 398 | 0.020 |
Why?
|
| Public Health | 1 | 2015 | 281 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1408 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 56 | 0.020 |
Why?
|
| Meat | 1 | 2012 | 45 | 0.020 |
Why?
|
| Vitamin E | 1 | 2012 | 63 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 63 | 0.020 |
Why?
|
| Heme | 1 | 2012 | 52 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 402 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 299 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 459 | 0.020 |
Why?
|
| DNA | 1 | 1996 | 1473 | 0.020 |
Why?
|
| Job Description | 1 | 2010 | 9 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 88 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1573 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 62 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 414 | 0.020 |
Why?
|
| Construction Materials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 1436 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1454 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 456 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 381 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 822 | 0.020 |
Why?
|
| Life Style | 2 | 2003 | 450 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 554 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1609 | 0.020 |
Why?
|
| Mass Screening | 1 | 2014 | 830 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 288 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 13028 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2192 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 439 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 852 | 0.020 |
Why?
|
| Great Lakes Region | 1 | 2003 | 1 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 175 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4529 | 0.010 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 1997 | 3 | 0.010 |
Why?
|
| Ventilation | 1 | 1993 | 5 | 0.010 |
Why?
|
| Netherlands | 1 | 1993 | 47 | 0.010 |
Why?
|
| United Kingdom | 1 | 1993 | 235 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1990 | 362 | 0.000 |
Why?
|
| Models, Biological | 1 | 1993 | 1443 | 0.000 |
Why?
|